Spinal Singularity to Present at the MedTech Strategist Innovation Summit

Press Release (ePRNews.com) - SAN CLEMENTE, Calif. - Nov 08, 2018 - Spinal Singularity, a developer and marketer of innovative treatments for bladder management, today announced that Bill Colone, Chief Executive Officer, will present at the upcoming MedTech Strategist Innovation Summit: Burlingame, Nov. 27-28, at the Hyatt Regency San Francisco Airport. Mr. Colone will present on Wednesday, Nov. 28 from 8:35-8:45 a.m. and will host a breakout session from 9:05-9:25 a.m. in the Harbour A meeting room.

For more information about the conference, please visit:

www.medtechstrategist.com

About Spinal Singularity Inc.

Spinal Singularity is a seed stage, venture-backed, medical device company developing products to improve the lives of patients with Spinal Injury. The company has developed the Connected Catheter, the first fully internal, smart catheter system for adult males with Urinary Retention. One Connected Catheter may replace up to 200 disposable intermittent catheters.

Spinal Singularity recently commenced Clinical Studies for the Connected Catheter in the USA. For more information or to see if you may qualify for this study, please visit the Company’s website at www.spinalsingularity.com  or contact us at info@spinalsingularity.com.

The Connected Catheter is currently an INVESTIGATIONAL DEVICE ONLY and Limited by Federal (or United States) law to investigational use.

Bill Colone, CEO
​Spinal Singularity
105 Avendia de la Estrella #3
​San Clemente, CA 92672 
​bill@spinalsingularity.com
(602) 681-3377

Source : Spinal Singularity
SHARE :  

You may also like this  

CATEGORIES : Healthcare Technology

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login

DISCLAIMER

If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.